Save your place

Sign in to WhoBought

Please try again later.

United Therapeutics Corporation (UTHR) institutional ownership

Latest close $535.83 Jul 21, 2026
Market cap$23.3B 52-week range SectorHealthcare
Institutional ownership · Q1 2026
43.9%
of UTHR shares outstanding
Top owners · Q1 2026
Avoro Capital Advisors LLC
Wellington Management Group LLP
Institutional activity · Q1 2026
Net sold $133M
397 buyers · 405 sellers

United Therapeutics Corporation (UTHR) price and institutional activity

Dates

Q1 2026

$1.6B bought by 397 investors
BlackRock$114MCitadel Advisors LLC$86M +395 more
$1.7B sold by 405 investors
Norges-$300MAQR Capital Management LLC-$227M +403 more
Bought Sold Totals per quarter; hover a bar for the names.

United Therapeutics Corporation (UTHR) ownership

Largest disclosed holders in Q1 2026.
Active funds 29.2%Index funds 14.7%Insiders 8.4%Retail and other 47.7%

Avoro Capital Advisors LLC

owns 6.2% of shares outstanding
Est. $1.6B · Shares: 2.6M

Wellington Management Group LLP

owns 5.3% of shares outstanding
Est. $1.3B · Shares: 2.3M

Renaissance Technologies LLC

View investor →
owns 4.2% of shares outstanding
Est. $1.1B · Shares: 1.8M

Janus Henderson Group PLC

owns 2.0% of shares outstanding
Est. $514M · Shares: 867K

AQR Capital Management LLC

owns 1.9% of shares outstanding
Est. $490M · Shares: 826K

Assetmark, Inc

owns 1.4% of shares outstanding
Est. $365M · Shares: 616K

Invesco Ltd.

View investor →
owns 1.4% of shares outstanding
Est. $361M · Shares: 608K

FMR LLC

owns 1.2% of shares outstanding
Est. $313M · Shares: 528K

United Therapeutics Corporation (UTHR) institutional activity · 802

Investor Type Est. change Change Δ Own Date
Norges · Exited −$300M
Change −602K Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$300M −602K −100.0% Q1 2026
AQR Capital Management LLC · Reduced −$227M
Change −455K Date Q1 2026
AQR Capital Management LLC Reduced· Q1 2026 −$227M −455K Q1 2026
BlackRock · Added +$114M
Change +229K Date Q1 2026
BlackRock Added· Q1 2026 +$114M +229K Q1 2026
Jane Street Group, LLC · Reduced −$107M
Change −214K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −$107M −214K Q1 2026
D. E. Shaw & Co., Inc. · Reduced −$104M
Change −208K Δ Own −67.7% Date Q1 2026
D. E. Shaw & Co., Inc. Reduced· Q1 2026 −$104M −208K −67.7% Q1 2026
Wellington Management Group LLP · Reduced −$88M
Change −177K Δ Own −7.3% Date Q1 2026
Wellington Management Group LLP Reduced· Q1 2026 −$88M −177K −7.3% Q1 2026
Citadel Advisors LLC Added· Q1 2026 +$86M +173K +92.7% Q1 2026
Victory Capital Management Inc · Reduced −$84M
Change −168K Date Q1 2026
Victory Capital Management Inc Reduced· Q1 2026 −$84M −168K Q1 2026
Fifth Third Bancorp · Added +$82M
Change +165K Date Q1 2026
Fifth Third Bancorp Added· Q1 2026 +$82M +165K Q1 2026
Soleus Capital Management, L.P. · Added +$63M
Change +127K Date Q1 2026
Soleus Capital Management, L.P. Added· Q1 2026 +$63M +127K Q1 2026
FMR LLC · Added +$62M
Change +125K Δ Own +30.8% Date Q1 2026
FMR LLC Added· Q1 2026 +$62M +125K +30.8% Q1 2026
Renaissance Technologies LLC Reduced· Q1 2026 −$61M −122K −6.4% Q1 2026
Vanguard · Added +$56M
Change +113K Date Q1 2026
Vanguard Added· Q1 2026 +$56M +113K Q1 2026
Orbimed Advisors LLC · Exited −$52M
Change −105K Δ Own −100.0% Date Q1 2026
Orbimed Advisors LLC Exited· Q1 2026 −$52M −105K −100.0% Q1 2026
Baillie Gifford & Co · Added +$52M
Change +105K Date Q1 2026
Baillie Gifford & Co Added· Q1 2026 +$52M +105K Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 802

Famous investor activity in United Therapeutics Corporation (UTHR)

United Therapeutics Corporation (UTHR) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Dzau Victor J. · Director 2 operations 3K
Owned 2K Trade date Jul 22, 2026 Filed date Jul 23, 2026
Dzau Victor J. Director 2 operations 3K 2K Jul 22, 2026 Jul 23, 2026
Maxwell Linda · Director 2 operations 2K
Owned 1K Trade date Jul 22, 2026 Filed date Jul 23, 2026
Maxwell Linda Director 2 operations 2K 1K Jul 22, 2026 Jul 23, 2026
Thompson Tommy G. · Director 2 operations 2K
Owned 1K Trade date Jul 22, 2026 Filed date Jul 23, 2026
Thompson Tommy G. Director 2 operations 2K 1K Jul 22, 2026 Jul 23, 2026
Tracey Kevin · Director Grant (A) 760
Owned 760 Trade date Jul 22, 2026 Filed date Jul 23, 2026
Tracey Kevin Director Grant (A) 760 760 Jul 22, 2026 Jul 23, 2026
Olian Judy D. · Director Grant (A) 760
Owned 760 Trade date Jul 22, 2026 Filed date Jul 23, 2026
Olian Judy D. Director Grant (A) 760 760 Jul 22, 2026 Jul 23, 2026
Malcolm Jan · Director 2 operations 2K
Owned 4K Trade date Jul 22, 2026 Filed date Jul 23, 2026
Malcolm Jan Director 2 operations 2K 4K Jul 22, 2026 Jul 23, 2026
Mesa Nilda · Director 2 operations 2K
Owned 1K Trade date Jul 22, 2026 Filed date Jul 23, 2026
Mesa Nilda Director 2 operations 2K 1K Jul 22, 2026 Jul 23, 2026
Sullivan Louis W. · Director Grant (A) 2K
Owned 2K Trade date Jul 22, 2026 Filed date Jul 23, 2026
Sullivan Louis W. Director Grant (A) 2K 2K Jul 22, 2026 Jul 23, 2026
Causey Christopher · Director Grant (A) 2K
Owned 2K Trade date Jul 22, 2026 Filed date Jul 23, 2026
Causey Christopher Director Grant (A) 2K 2K Jul 22, 2026 Jul 23, 2026
Patusky Christopher · Director Grant (A) 2K
Owned 2K Trade date Jul 22, 2026 Filed date Jul 23, 2026
Patusky Christopher Director Grant (A) 2K 2K Jul 22, 2026 Jul 23, 2026
Giltner Richard · Director Grant (A) 760
Owned 760 Trade date Jul 22, 2026 Filed date Jul 23, 2026
Giltner Richard Director Grant (A) 760 760 Jul 22, 2026 Jul 23, 2026
Kurzweil Ray · Director 2 operations 2K
Owned 1K Trade date Jul 22, 2026 Filed date Jul 23, 2026
Kurzweil Ray Director 2 operations 2K 1K Jul 22, 2026 Jul 23, 2026
Rothblatt Martine A. · Director 14 operations −$5.0M
Price $524.27–$539.47 Qty −10K Owned 324K ΔOwn −2.8% Trade date Jul 22, 2026 Filed date Jul 23, 2026
Rothblatt Martine A. Director 14 operations $524.27–$539.47 −10K −$5.0M 324K −2.8% Jul 22, 2026 Jul 23, 2026
Rothblatt Martine A. · Director 2 operations 0
Price $135.42 Owned 294K Trade date Jul 22, 2026 Filed date Jul 23, 2026
Rothblatt Martine A. Director 2 operations $135.42 0 294K Jul 22, 2026 Jul 23, 2026
Rothblatt Martine A. · Director 11 operations −$5.1M
Price $524.37–$536.37 Qty −10K Owned 324K ΔOwn −2.8% Trade date Jul 21, 2026 Filed date Jul 22, 2026
Rothblatt Martine A. Director 11 operations $524.37–$536.37 −10K −$5.1M 324K −2.8% Jul 21, 2026 Jul 22, 2026
15 of 46
15 of 46 Sign in to continue to older insider transactions.

United Therapeutics Corporation (UTHR) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Capital Management 2.3M
% of shares outstanding 5.2% Filing date Apr 30, 2026
Vanguard Capital Management 2.3M 5.2% Apr 30, 2026
1 of 1

United Therapeutics Corporation (UTHR) ownership FAQ

Who owns UTHR?

Institutions hold 43.9% of UTHR shares in the Q1 2026 snapshot. The largest disclosed owners include Avoro Capital Advisors LLC, Wellington Management Group LLP, Renaissance Technologies LLC. The ownership chart shows each group's share of total shares outstanding from the latest disclosed filings. Retail and other includes everyone who does not file, not a tracked group.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.